PLASMA LEVELS OF PLASMINOGEN ACTIVATOR INHIBITOR-1 IN PATIENTS WITH TYPE 2 DIABETES AFTER LIPOPOLYSACCHARIDE INJECTION

被引：0
|
作者：
Berg, R. M. G. [1 ]
Andreasen, A. S. [1 ]
Pedersen, B. K. [1 ]
Moller, K. [1 ,2 ]
机构：
[1] Univ Copenhagen Hosp, Rigshosp, Ctr Inflammat & Metab, Dept Infect Dis, DK-2100 Copenhagen, Denmark
[2] Univ Copenhagen Hosp, Rigshosp, Intens Care Unit 4131, DK-2100 Copenhagen, Denmark
来源：
INTENSIVE CARE MEDICINE | 2009年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
0947
引用
收藏
页码：244 / 244
页数：1
相关论文
共 50 条
  • [31] The plasma levels of prostanoids and plasminogen activator inhibitor-1 in primary and secondary thrombocytosis
    Birdane, A
    Haznedaroglu, IC
    Bavbek, N
    Kosar, A
    Büyükasik, Y
    Özcebe, O
    Dündar, SV
    Kirazli, S
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2005, 11 (02) : 197 - 201
  • [32] Antiplatelet therapy effectively reduces plasma plasminogen activator inhibitor-1 levels
    Sakata, T.
    Kario, K.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 82 - 83
  • [33] PLASMINOGEN-ACTIVATOR INHIBITOR-1 LEVELS IN PLASMA ARE ASSOCIATED WITH INSULIN RESISTANCE
    VANLOON, BJP
    KLUFT, C
    RADDER, JK
    BLANKENSTEIN, MA
    MEINDERS, AE
    DIABETOLOGIA, 1992, 35 : A9 - A9
  • [34] Determinants of plasma levels of plasminogen activator inhibitor-1 - A study of normotensive twins
    Cesari, M
    Sartori, MT
    Patrassi, GM
    Vettore, S
    Rossi, GP
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (02) : 316 - 320
  • [35] PLASMINOGEN-ACTIVATOR INHIBITOR-1 PLASMA-LEVELS AND CORONARY RESTENOSIS
    HUBER, K
    BINDER, BR
    CIRCULATION, 1992, 86 (05) : 1661 - 1662
  • [36] The plasma levels of prostanoids and plasminogen activator inhibitor-1 in primary and secondary thrombocytosis
    Birdane, A
    Haznedaroglu, IC
    Özath, D
    Sayinalp, N
    Kosar, A
    Büyükasik, Y
    Özcebe, O
    Karakus, S
    Dündar, SV
    Kirazli, S
    EXPERIMENTAL HEMATOLOGY, 2000, 28 (07) : 120 - 120
  • [37] Strong association of ischaemic stroke in type 2 diabetes patients with decreased insulin sensitivity and increased plasminogen activator inhibitor-1 levels
    Mijajlovic, M
    Lalic, N
    Jotic, A
    Jovanovic, Z
    Pavlovic, A
    Trajkovic, JZ
    Kostic, V
    Sternic, NC
    JOURNAL OF NEUROLOGY, 2004, 251 : 80 - 80
  • [38] Plasma tissue plasminogen activator and plasminogen activator inhibitor-1 in hospitalized COVID-19 patients
    Yu Zuo
    Mark Warnock
    Alyssa Harbaugh
    Srilakshmi Yalavarthi
    Kelsey Gockman
    Melanie Zuo
    Jacqueline A. Madison
    Jason S. Knight
    Yogendra Kanthi
    Daniel A. Lawrence
    Scientific Reports, 11
  • [39] Plasma tissue plasminogen activator and plasminogen activator inhibitor-1 in hospitalized COVID-19 patients
    Zuo, Yu
    Warnock, Mark
    Harbaugh, Alyssa
    Yalavarthi, Srilakshmi
    Gockman, Kelsey
    Zuo, Melanie
    Madison, Jacqueline A.
    Knight, Jason S.
    Kanthi, Yogendra
    Lawrence, Daniel A.
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [40] Empagliflozin Decreases the Plasma Concentration of Plasminogen Activator Inhibitor-1 (PAI-1) in Patients with Type 2 Diabetes: Association with Improvement of Fibrinolysis
    Niitani, Takafumi
    Sakurai, Shintaro
    Jojima, Teruo
    Iijima, Toshie
    Tomaru, Takuya
    Usui, Isao
    Aso, Yoshimasa
    DIABETES, 2020, 69
12345